Pengju Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Pengju Jiang has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
- Jianhao Wang
Changzhou University
22 shared publications Lin Qiu
School of Pharmacy, Changzhou University, Changzhou, Jiangsu 213164, China
20 shared publications- Lin Qiu
School of Pharmaceutical Engineering and Life Science, Changzhou University, Changzhou, Jiangsu, P. R. China
14 shared publications Jianhao Wang
13 shared publicationsJinchen Li
School of Pharmaceutical Engineering and Life Science, Changzhou University, Changzhou, Jiangsu, People's Republic of China
11 shared publicationsLi Liu
School of Pharmaceutical Engineering and Life Science, Changzhou University, Changzhou, P. R. China
11 shared publications
Latest Publications
- 26 January 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 232, 123413
Collagen hydrogel with multiple antimicrobial mechanisms as anti-bacterial wound dressing
- 26 January 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 232, 123413
Collagen hydrogel with multiple antimicrobial mechanisms as anti-bacterial wound dressing
- 21 January 2023
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 81
Metal-phenolic network for cancer therapy
- 21 January 2023
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 81
Metal-phenolic network for cancer therapy
- 9 September 2022
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 76
Glucose oxidase loaded thermosensitive hydrogel as an antibacterial wound dressing
- 9 September 2022
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 76
Glucose oxidase loaded thermosensitive hydrogel as an antibacterial wound dressing
- 25 August 2022
- Published by Springer Nature in Pharmaceutical Research
- Vol. 39 (10) , 2475-2486
Progress in Intradermal and Transdermal Gene Therapy with Microneedles
Gene therapy is one of the most widely studied treatments and has the potential to treat a variety of intractable diseases. The skin's limited permeability, as the body's initial protective barrier, drastically inhibits the delivery effect of gene medicine. Given the potential adverse effects and physicochemical features of the medications, improving generic drug penetration into the skin barrier and achieving an effective level of target tissues remains a challenge. Microneedles have made tremendous improvements in aided gene transfer and medication delivery as a unique method. Microneedles offer the advantage of being minimally invasive and painless, as well as the ability to distribute gene medicines straight through the stratum corneum. Microneedles have been used to penetrate skin tissue with various nucleic acids and medicines in recent years, allowing for a wide range of applications in the treatment of skin ailments. This review focuses on skin-related disorders and immunity, and it primarily discusses the progress of microneedle transdermal gene therapy in recent years. It also complements the current major vectors and related microneedle gene therapy applications.
- 25 August 2022
- Published by Springer Nature in Pharmaceutical Research
- Vol. 39 (10) , 2475-2486
Progress in Intradermal and Transdermal Gene Therapy with Microneedles
Gene therapy is one of the most widely studied treatments and has the potential to treat a variety of intractable diseases. The skin's limited permeability, as the body's initial protective barrier, drastically inhibits the delivery effect of gene medicine. Given the potential adverse effects and physicochemical features of the medications, improving generic drug penetration into the skin barrier and achieving an effective level of target tissues remains a challenge. Microneedles have made tremendous improvements in aided gene transfer and medication delivery as a unique method. Microneedles offer the advantage of being minimally invasive and painless, as well as the ability to distribute gene medicines straight through the stratum corneum. Microneedles have been used to penetrate skin tissue with various nucleic acids and medicines in recent years, allowing for a wide range of applications in the treatment of skin ailments. This review focuses on skin-related disorders and immunity, and it primarily discusses the progress of microneedle transdermal gene therapy in recent years. It also complements the current major vectors and related microneedle gene therapy applications.
- 29 March 2022
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 19 (5) , 1647-1655
A Facile Way To Improve the Bioavailability of Nanomedicine Based on the Threshold Theory
One of the most significant barriers to the clinical transformation of nanomedicines is low drug distribution in solid tumors due to quick clearance of nanomedicine after injection. Studies have revealed that the distribution of nanomedicine in tumor sites can be considerably improved when the number of nanoparticles supplied in a short period surpasses the threshold. Most routinely employed nanomaterials have dose-related safety concerns. To resolve this problem, we use highly biocompatible albumin to construct blank nanoparticles and doxorubicin loading nanoparticles. Under the guidance of the threshold theory, when the quantity of drug loading nanoparticles is constant, the drug delivery effectiveness improves with the addition of blank nanoparticles. This enhanced impact was verified both in vitro and in vivo. The area under the curve of the high dose group (19.5 × 1011) is 2.5 times higher than that of the low dose group (6.5 × 1011). In addition, the drug distribution of the high dose group at the tumor site was also improved by 1.5 times compared with the low dose group. The results of histopathological sections also showed that the administration of excess blank nanoparticles within 24 h has no damage to the animals. This study contributes to the clinical transition of nanomedicine by providing fresh ideas for anticancer nanomedicine research.
- 29 March 2022
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 19 (5) , 1647-1655
A Facile Way To Improve the Bioavailability of Nanomedicine Based on the Threshold Theory
One of the most significant barriers to the clinical transformation of nanomedicines is low drug distribution in solid tumors due to quick clearance of nanomedicine after injection. Studies have revealed that the distribution of nanomedicine in tumor sites can be considerably improved when the number of nanoparticles supplied in a short period surpasses the threshold. Most routinely employed nanomaterials have dose-related safety concerns. To resolve this problem, we use highly biocompatible albumin to construct blank nanoparticles and doxorubicin loading nanoparticles. Under the guidance of the threshold theory, when the quantity of drug loading nanoparticles is constant, the drug delivery effectiveness improves with the addition of blank nanoparticles. This enhanced impact was verified both in vitro and in vivo. The area under the curve of the high dose group (19.5 × 1011) is 2.5 times higher than that of the low dose group (6.5 × 1011). In addition, the drug distribution of the high dose group at the tumor site was also improved by 1.5 times compared with the low dose group. The results of histopathological sections also showed that the administration of excess blank nanoparticles within 24 h has no damage to the animals. This study contributes to the clinical transition of nanomedicine by providing fresh ideas for anticancer nanomedicine research.
- 1 February 2022
- Published by American Scientific Publishers in Journal of Biomedical Nanotechnology
- Vol. 18 (2) , 435-445
Small Molecule Modifications Significantly Increase the Transfection Efficiency of Low-Molecular Polymer
Gene vectors with high biocompatibility and transfection efficiency are critical for successful gene therapy. PEI 25K (Polyethyleneimine 25K) is a common polymeric gene vector that has been employed as a positive control material in gene transfection studies due to its good performance in endosome escape. PEI 25K’s indegradability and abundance of positive charges, on the other hand, cause toxicity in cells, limiting its use. In this study, we developed the PEI-ER non-viral vector by adding an endoplasmic reticulum (ER) targeting ligand to low molecular weight PEI 1.8K. These small molecule modifications dramatically improved PEI transfection efficiency while barely interfering with compatibility. PEI-ER/DNA complexes were discovered to enter the cell via caveolin-mediated endocytosis, avoiding destruction in the endosome. We believe that this little chemical alteration is a simple solution to enhance the efficacy of cationic polymer vectors in gene transport, and it has a lot of medicinal applications.
- 1 February 2022
- Published by American Scientific Publishers in Journal of Biomedical Nanotechnology
- Vol. 18 (2) , 435-445
Small Molecule Modifications Significantly Increase the Transfection Efficiency of Low-Molecular Polymer
Gene vectors with high biocompatibility and transfection efficiency are critical for successful gene therapy. PEI 25K (Polyethyleneimine 25K) is a common polymeric gene vector that has been employed as a positive control material in gene transfection studies due to its good performance in endosome escape. PEI 25K’s indegradability and abundance of positive charges, on the other hand, cause toxicity in cells, limiting its use. In this study, we developed the PEI-ER non-viral vector by adding an endoplasmic reticulum (ER) targeting ligand to low molecular weight PEI 1.8K. These small molecule modifications dramatically improved PEI transfection efficiency while barely interfering with compatibility. PEI-ER/DNA complexes were discovered to enter the cell via caveolin-mediated endocytosis, avoiding destruction in the endosome. We believe that this little chemical alteration is a simple solution to enhance the efficacy of cationic polymer vectors in gene transport, and it has a lot of medicinal applications.
- 1 February 2022
- Published by American Scientific Publishers in Journal of Biomedical Nanotechnology
- Vol. 18 (2) , 571-580
Liposome Loaded Ion/Temperature Dual Responsive Gellan Gum Hydrogel as Potential Nasal-To-Brain Delivery System
Intranasal administration, which can bypass the blood–brain barrier (BBB), is widely recognized as a promising strategy for high-efficiency drug delivery to the brain. Herein, for the purpose of effectively delivering drugs to the brain via intranasal administration, glutathione (GSH)-modified gellan gum (GSH-GG) with ion/temperature dual responsive properties was synthesized and encapsulated on galanthamine hydrobromide (GH)-loaded liposomes (GH-Lipo) for effective GH delivery to the brain (GH-Lipo@GSH-GG). Our results demonstrated that GSH-GG greatly decreased the gelation temperature of GG from 44.0 °C to 22.1 °C without compromising its ion responsiveness. Moreover, GSH-GG had a good protection ability for GH-loaded liposomes without affecting its drug release. Most importantly, the finally obtained GH-Lipo@GSHGG showed acceptable targeted delivery of GH to the brain upon in vivo administration. Therefore, this formulation can be employed as a potential delivery system in nasal-to-brain delivery.
- 1 February 2022
- Published by American Scientific Publishers in Journal of Biomedical Nanotechnology
- Vol. 18 (2) , 571-580
Liposome Loaded Ion/Temperature Dual Responsive Gellan Gum Hydrogel as Potential Nasal-To-Brain Delivery System
Intranasal administration, which can bypass the blood–brain barrier (BBB), is widely recognized as a promising strategy for high-efficiency drug delivery to the brain. Herein, for the purpose of effectively delivering drugs to the brain via intranasal administration, glutathione (GSH)-modified gellan gum (GSH-GG) with ion/temperature dual responsive properties was synthesized and encapsulated on galanthamine hydrobromide (GH)-loaded liposomes (GH-Lipo) for effective GH delivery to the brain (GH-Lipo@GSH-GG). Our results demonstrated that GSH-GG greatly decreased the gelation temperature of GG from 44.0 °C to 22.1 °C without compromising its ion responsiveness. Moreover, GSH-GG had a good protection ability for GH-loaded liposomes without affecting its drug release. Most importantly, the finally obtained GH-Lipo@GSHGG showed acceptable targeted delivery of GH to the brain upon in vivo administration. Therefore, this formulation can be employed as a potential delivery system in nasal-to-brain delivery.
- 4 August 2021
- Published by Wiley in Macromolecular Rapid Communications
- Vol. 42 (19) , 2100264
Modulation of Aggregation‐Caused Quenching to Aggregation‐Induced Emission: Finding a Biocompatible Polymeric Theranostics Platform for Cancer Therapy
Dual intramolecular FRET polymers are synthesized via Suzuki coupling and their luminescence characteristics from aggregation‐caused quenching (ACQ) to aggregation‐induced emission (AIE) is modulated conveniently by adjusting the charged ratios. The finally obtained AIE polymer is further employed to construct doxorubicin loaded nanoparticles as a promising theranostics platform for cancer therapy.
- 4 August 2021
- Published by Wiley in Macromolecular Rapid Communications
- Vol. 42 (19) , 2100264
Modulation of Aggregation‐Caused Quenching to Aggregation‐Induced Emission: Finding a Biocompatible Polymeric Theranostics Platform for Cancer Therapy
Dual intramolecular FRET polymers are synthesized via Suzuki coupling and their luminescence characteristics from aggregation‐caused quenching (ACQ) to aggregation‐induced emission (AIE) is modulated conveniently by adjusting the charged ratios. The finally obtained AIE polymer is further employed to construct doxorubicin loaded nanoparticles as a promising theranostics platform for cancer therapy.